Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

Study ID: NCT05911295
Start Date: 2023-09-22
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

400

Intervention / Treatment

disitamab vedotin

pembrolizumab

gemcitabine

cisplatin

carboplatin

Sponsor

Seagen, a wholly owned subsidiary of Pfizer

Source: clinicaltrials.gov

Share:
Add to list

Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)

Study ID: NCT06194539
Start Date: 2024-02
End Date: 2026-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

75

Intervention / Treatment
Sponsor

Bar-Chama, Natan, M.D.

Source: clinicaltrials.gov

Share:
Add to list

Cognitive Changes of IDH-mutant and IDH-wildtype Glioma Patients After Chemoradiotherapy With Radiation Dose to the Resting State Networks

Study ID: NCT04975139
Start Date: 2020-09-02
End Date: 2033-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

96

Intervention / Treatment

RS-fMRI

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Pediatric Oncology Recovery Trial After Surgery

Study ID: NCT04344899
Start Date: 2019-07-23
End Date: 2028-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

288

Intervention / Treatment

Observational

Sponsor

University of Colorado, Denver

Source: clinicaltrials.gov

Share:
Add to list

Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy

Study ID: NCT06937177
Start Date: 2025-04-28
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

TCMCB07

Placebo

Sponsor

Endevica Bio

Source: clinicaltrials.gov

Share:
Add to list

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Study ID: NCT05827081
Start Date: 2024-02-28
End Date: 2030-09-20
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1400

Intervention / Treatment

Ribociclib

Letrozole

Anastrozole

Goserelin

Leuprolide

Exemestane

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Multicenter HomeVENT: Home Values and Experiences Navigation Track

Study ID: NCT06102330
Start Date: 2024-02-06
End Date: 2030-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

600

Intervention / Treatment

HomeVENT decision support tool

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Effects of Personalized Exercise Prescriptions Through Mobile Health on Physical Activity and Health Outcomes in the Cancer Survivors

Study ID: NCT06840028
Start Date: 2025-03-01
End Date: 2026-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

mHealth/sFitRx

Fitness Tracker

Sponsor

The University of Tennessee, Knoxville

Source: clinicaltrials.gov

Share:
Add to list

Comprehensive Connected Cancer Care (C4): Intervention Evaluation

Study ID: NCT06326567
Start Date: 2024-02-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

300

Intervention / Treatment

C4 Program

Sponsor

Timothy Mullett

Source: clinicaltrials.gov

Share:
Add to list

Liposomal Bupivacaine and Transoral Robotic Surgery

Study ID: NCT05862792
Start Date: 2023-06-01
End Date: 2026-01-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Liposomal bupivacaine

Sponsor

Geisinger Clinic

Source: clinicaltrials.gov

Share:
Add to list